Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,264.00
Bid: 12,280.00
Ask: 12,282.00
Change: 146.00 (1.20%)
Spread: 2.00 (0.016%)
Open: 12,244.00
High: 12,384.00
Low: 12,228.00
Prev. Close: 12,118.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BRIEFING: Barclays buys Tesco's retail banking business

Fri, 09th Feb 2024 07:51

(Alliance News) - Stocks in London are called to open higher on Friday, closing off a busy corporate week.

In early economic news, numbers from Destatis confirmed that consumer price inflation in Germany cooled to 2.9% in January.

On the corporate front, Barclays has agreed to buy Tesco's retail banking business. The two FTSE 100 companies have also agreed a long-term strategic partnership.

Here is what you need to know at the London market open:

----------

MARKETS

----------

FTSE 100: called up slightly at 7,597.80

----------

Hang Seng: closed up 0.8% at 15,746.58

Nikkei 225: closed up 0.1% at 36,897.42

S&P/ASX 200: closed up 0.1% at 7,644.80

----------

DJIA: closed up 48.97 points, 0.1%, at 38,726.33

S&P 500: closed up 2.85 points, 0.1%, at 4,997.91

Nasdaq Composite: closed up 37.07 points, 0.2%, to 15,793.72

----------

EUR: up at USD1.0780 (USD1.0763)

GBP: up at USD1.2626 (USD1.2609)

USD: down at JPY149.27 (JPY149.39)

Gold: up at USD2,033.41 per ounce (USD2,029.31)

(Brent): up at USD81.45 a barrel (USD81.02)

(changes since previous London equities close)

----------

ECONOMICS

----------

Friday's key economic events still to come:

08:30 EST Canada unemployment

11:00 GMT Ireland industrial production

13:00 EST US Baker Hughes oil rig count

----------

Consumer price inflation in Germany cooled to 2.9% in January, numbers from Destatis confirmed on Friday. According to a Destatis, the consumer price index rose by 2.9% in January from a year before, slowing from a 3.7% annual rise in December. This came in line with a previous estimate. On a harmonised basis, allowing for EU-wide comparison, the rate of inflation cooled to 3.1% in January from 3.8% in December. On a monthly basis, consumer prices rose 0.2% in January from December, picking up speed from a 0.1% rise in December from November. On a harmonised basis, consumer prices fell 0.2% in January from December. They had risen 0.2% in December from November.

----------

BROKER RATING CHANGES

----------

Deutsche Bank cuts AstraZeneca to 'sell' (hold) - price target 9,500 (11,000) pence

----------

Berenberg starts Keller Group with 'buy' - price target 1,250 pence

----------

Berenberg starts Kier Group with 'buy' - price target 210 pence

----------

COMPANIES - FTSE 100

----------

Barclays said it has bought Tesco's retail banking business, which includes credit cards, unsecured personal loans, deposits and the operating infrastructure. Additionally, Barclays UK will enter into a long-term, exclusive strategic partnership with Tesco Stores for an initial period of 10 years to market and distribute credit cards, unsecured personal loans and deposits using the Tesco brand, as well as explore other opportunities to offer financial services to Tesco customers. "Barclays is a leading consumer bank in the UK. This strategic relationship with the UK's largest retailer will help create new distribution channels for our unsecured lending and deposit businesses. We are able to bring our expertise in partnership cards developed over decades in the US to enhance further the highly successful Tesco Clubcard loyalty scheme," said Barclays Chief Executive Venkatakrishnan. Rival UK supermarket chain J Sainsbury last month announced a phased withdrawal from its core banking business. This followed a review of its Financial Services division as part of its 'Food First' strategy.

----------

COMPANIES - FTSE 250

----------

Bellway said that in the six months ended January 31, housing revenue amounted over GBP1.25 billion, down from GBP1.80 billion a year earlier but in line with the board's expectations. Total housing completions came in at 4,092 homes, down from 5,695 homes. "Bellway has delivered another resilient performance in a period of challenging trading conditions. While the economic backdrop remains uncertain, the gradual reduction in mortgage interest rates through the first half has eased affordability constraints and we are encouraged by the seasonal pick-up in customer leads and an improvement in reservations since the start of the new calendar year," said CEO Jason Honeyman.

----------

Victrex noted a "soft start" to its financial year, as it updated markets on its first quarter, ended December 31. Quarterly revenue fell 22% to GBP61.2 million from GBP78.8 million a year earlier. Volumes fell 21% to 751 tonnes from 948 tonnes. Looking ahead, Vistry noted an improvement seen in January, the start of its second quarter, but warned that "visibility remains limited." CEO Jakob Sigurdsson added: "January trading was solid and ended slightly ahead of the prior year comparative. However, we are mindful of the soft start and limited visibility of an uptick in several end-markets."

----------

OTHER COMPANIES

----------

Air Astana, an airline group in Central Asia and the Caucasus region, announced the price for its initial public offering in London and on two local exchanges in Kazakhstan. The IPO will include the sale of existing shares held by aerospace firm BAE Systems. Air Astana said the IPO was oversubscribed "multiple times". It set the price for its global depositary receipts - each representing four shares - at USD9.50, within its previously announced range of USD8.50 to USD11.00. This will give Air Astana a market capitalisation at the IPO price of USD847 million. BAE will sell 7.5 million GDRs in the domestic offering and 14.2 million in the global offering. The IPO will raise USD370 million, including an over-allotment option offered by BAE. Of this, USD120 million will go to Air Astana for growth initiatives.

----------

OpenAI chief Sam Altman is seeking to raise trillions of dollars to reshape the global semiconductor industry, and has held talks with potential investors including the UAE government, the Wall Street Journal reported Thursday. Altman is reportedly looking to resolve some of the biggest challenges faced by the rapidly-expanding artificial intelligence sector – including a shortage of the expensive computer chips needed to power large-language models like OpenAI's ChatGPT. The global chip industry is currently dominated by just a few firms, including Taiwan Semiconductor Manufacturing Co and California-based Nvidia. While many countries have unveiled plans to support domestic chip production, the financial support they have offered pales in comparison with the vast sums of money Altman has reportedly been discussing with investors. The Journal estimated that the total cost of realising Altman's project could be as much as USD7 trillion. This is roughly a trillion dollars more than the market value of the world's two largest public companies – Apple and Microsoft , the latter which backs OpenAI – combined.

----------

By Sophie Rose, Alliance News senior reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
8 May 2024 19:10

Sector movers: Aerospace and Defence, Pharma pace gains

(Sharecast News) - London's main stock market gauges continued to push higher in the middle of the week, even as investors waited on the Bank of England's policy announcement on the following day.

Read more
8 May 2024 17:46

FTSE 100 hits record high, pound slips ahead of BoE verdict

FTSE 100 up 0.5%, FTSE 250 adds 0.4%

*

Read more
8 May 2024 16:36

London close: Stocks rise further ahead of BoE decision

(Sharecast News) - London's stock markets closed with gains on Wednesday, bolstered by a dip in the value of the pound against both the dollar and the euro.

Read more
8 May 2024 09:44

AstraZeneca says withdraws Covid vaccine "for commercial reasons"

(Alliance News) - Drugmaker AstraZeneca PLC said Wednesday that it has withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemic, citing "commercial reasons" and a surplus of updated jabs.

Read more
8 May 2024 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.